Women should be fully informed of the potential benefits and harms before screening mammography.
作者信息
Kerlikowske K, Ernster V L
机构信息
Department of Medicine, University of California, San Francisco School of Medicine, USA.
出版信息
West J Med. 2000 Nov;173(5):313-4. doi: 10.1136/ewjm.173.5.313.
Abstract
摘要
相似文献
1
Women should be fully informed of the potential benefits and harms before screening mammography.在进行乳腺钼靶筛查之前，应让女性充分了解其潜在的益处和危害。
West J Med. 2000 Nov;173(5):313-4. doi: 10.1136/ewjm.173.5.313.
2
US women's attitudes to false-positive mammography results and detection of ductal carcinoma in situ: cross-sectional survey.美国女性对乳腺钼靶检查假阳性结果及导管原位癌检测的态度：横断面调查
West J Med. 2000 Nov;173(5):307-12. doi: 10.1136/ewjm.173.5.307.
3
Ductal carcinoma in situ: the mammographer's perspective.
AJR Am J Roentgenol. 1994 Mar;162(3):585-91. doi: 10.2214/ajr.162.3.8109501.
4
Ductal carcinoma in situ of the breast: mammographic-pathologic correlation.乳腺导管原位癌：乳腺钼靶X线摄影与病理的相关性
AJR Am J Roentgenol. 1998 Jun;170(6):1543-9. doi: 10.2214/ajr.170.6.9609171.
5
Treatment uncertainties surround early diagnosis of breast cancer.
Ann Intern Med. 1997 Apr 15;126(8):I53-4.
6
Screening--a cruel deception.筛查——一场残酷的骗局。
Practitioner. 2002 May;246(1634):293.
7
Radiological case of the month. Ductal carcinoma in situ.
J Ark Med Soc. 1996 Jan;92(8):415-8.
8
Mammographic follow-up of clustered microcalcifications.乳腺钼靶对簇状微小钙化灶的随访
AJR Am J Roentgenol. 1995 Dec;165(6):1550-1. doi: 10.2214/ajr.165.6.7484612.
9
Detection and treatment of ductal carcinoma in situ of the breast.乳腺导管原位癌的检测与治疗
JAMA. 1996 Sep 18;276(11):869; author reply 870-71. doi: 10.1001/jama.276.11.869b.
10
Detection and treatment of ductal carcinoma in situ of the breast.乳腺导管原位癌的检测与治疗
JAMA. 1996 Sep 18;276(11):869-70; author reply 870-71. doi: 10.1001/jama.1996.03540110023015.
引用本文的文献
1
Misconceptions about efficacy of mammography screening: a public health dilemma.关于乳腺钼靶筛查效果的误解：一个公共卫生困境。
J Epidemiol Community Health. 2001 Nov;55(11):799-803. doi: 10.1136/jech.55.11.799.
本文引用的文献
1
Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.70至79岁女性的持续性乳腺钼靶筛查：对预期寿命和成本效益的影响。
JAMA. 1999 Dec 8;282(22):2156-63. doi: 10.1001/jama.282.22.2156.
2
Psychologic distress in women with abnormal findings in mass mammography screening.
Cancer. 1999 Mar 1;85(5):1114-8. doi: 10.1002/(sici)1097-0142(19990301)85:5<1114::aid-cncr15>3.0.co;2-y.
3
Outcomes of modern screening mammography.现代乳腺钼靶筛查的结果。
J Natl Cancer Inst Monogr. 1997(22):105-11. doi: 10.1093/jncimono/1997.22.105.
4
Breast screening: adverse psychological consequences one month after placing women on early recall because of a diagnostic uncertainty. A multicentre study.乳房筛查：因诊断不确定而将女性列入早期召回名单一个月后的不良心理后果。一项多中心研究。
J Med Screen. 1997;4(3):158-68. doi: 10.1177/096914139700400309.
5
Positive predictive value of screening mammography by age and family history of breast cancer.按年龄和乳腺癌家族史划分的乳腺钼靶筛查的阳性预测值
JAMA. 1993 Nov 24;270(20):2444-50.
Zotero 插件